BILLERICA, Mass., Sept. 23, 2013 /PRNewswire/ -- In an invited talk at Europe's 2013 MipTec Conference and Exhibition, Seahorse Bioscience Chief Executive Officer, Jay Teich, will discuss the factors that enabled Seahorse to maintain steady growth while the market for life sciences tools declined in 2012.
Mr. Teich's presentation, 'Growing in a World of Budget Constraints,' will address the challenging markets faced by emerging technology companies that relied on government research funding during a period of high unpredictability in late 2012 and early 2013.
"American research scientists have struggled through difficult times in the past two years with the uncertainties of a presidential election, sequestration, and an unsigned NIH budget – and their funding continues to be in jeopardy. European research and development support has been equally challenged by the austerity measures throughout the years," stated Mr. Teich. "Despite this, Seahorse has continued to grow at double-digit rates. At MipTec I will present the three primary factors that I believe enabled our survival and success in a tough market environment."
Being held 24th - 26th September, 2013, in Basel Switzerland, MipTec is Europe's leading event for drug discovery and life sciences research, providing a platform for strategic and business-oriented networking, and the opportunity for scientists to gain expert insights into new technology, and leading-edge developments that are accelerating life sciences research and drug discovery. Mr. Teich's presentation is part of the Jumpstarting Innovations in Life Sciences Forum taking place Thursday, 26th September 2013, 9:00 am – 12:00 noon, in Room 1, Exhibition Area Hall 4.1.
Seahorse Bioscience provides industry-leading analytical instruments, and consumable products for biological research and drug discovery. The XFe Extracellular Flux Analyzer and stress test kits are the driving force behind cell-metabolism research, simultaneously measuring the two major energy-producing pathways within the cell – mitochondrial respiration and glycolysis – in real-time, in a microplate. This novel technology enables scientists to better understand the connection of physiological traits of cells with genomic and proteomic data, and this knowledge is generating new insights into mitochondrial function, leading to a greater understanding and treatments of disease. Seahorse Bioscience's Switzerland Distributor Bucher Biotec will represent XF technology at booth C34.
The MipTec Conference and Exhibition offers professionals in the field of drug discovery and life sciences a platform to discuss and share knowledge about the latest breakthroughs in new technologies that have enabled pharmacogenomics to deliver personalized medicines to some patient populations, as well as cell-based therapies that are advancing to the clinic, and exciting developments in biological engineering that are enabling the interrogation of novel disease mechanisms. Learn more about MipTec.
About Seahorse Bioscience
Seahorse Bioscience XFe Extracellular Flux Analyzers and stress test kits are the industry standard in cellular bioenergetic measurements. Over 2,500 scientists worldwide are advancing their research in understanding the role of cell metabolism in Neurodegeneration, Aging, Cancer, Cardiovascular, Cell Physiology, Toxicology and Hepatobiology, Immunology, Infectious Diseases, Mitochondrial Diseases, Model Organisms, Obesity, Diabetes, Metabolic Disorders, Screening, and Translational Medicine. Founded in 2001, Seahorse Bioscience is headquartered in Billerica, Massachusetts, U.S., and has regional offices in Copenhagen, Denmark; and Shanghai, China. Learn more about Seahorse Bioscience.
Marketing Communications Manager
SOURCE Seahorse Bioscience